November 21, 2024

Webinar: The Ultimate Guide to PDX Mouse Clinical Trials

October 30, 2024

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test

October 1, 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

August 21, 2024

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

May 24, 2024

Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

May 23, 2024

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies

Contact Us
Databases
CrownLink

US Tel: +1 858 622 2900

UK Tel: +44 870 242 2900

All Contact Information

Our Services
Our Science
About Us
Contact us

Blog

Ovarian Cancer

Developing Effective Dosing Strategies by Leveraging 3D In Vitro Models

8 minute read

Developing Effective Dosing Strategies by Leveraging 3D In Vitro Models

July 29, 2022

Novel Drug Formulation Delivers Immunotherapy To Ovarian Cancer Cells

3 minute read

Novel Drug Formulation Delivers Immunotherapy To Ovarian Cancer Cells

August 18, 2015

Nanoparticles: The Trojan Horse That Defeats Ovarian Cancer By Releasing Dendritic Cells

3 minute read

Nanoparticles: The Trojan Horse That Defeats Ovarian Cancer By Releasing Dendritic Cells

June 23, 2015

Search our Blog

Categories

About Us

Our Company
Our Purpose
Our Responsibility
Leadership
News & Events

Our Services

Therapeutic Areas
Model Systems
Technologies
Service Type

Resources

Blog
Preclinical Models
Publications
Factsheets
White Papers
Ebooks
Webinars

Platforms

OncoExpress™
XenoBase®
MuBase®
HuBase™
OrganoidBase™
CrownLink™

Talk To Us

+1 858 381 3547
Contact Us
Distributors
LinkedIn
X

© 2024 Crown Bioscience. All Rights Reserved.

Privacy Policy. Manage Privacy Preferences

© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy

2024-05-23

2022-12-16